Advanced Bioactive Polymers and Materials for Nerve Repair: Strategies and Mechanistic Insights
Source abstract
Abstract
Bioactive materials have recently shown potential in nerve repair and regeneration by promoting the growth of new cells, tissue repair, and restoring nerve function. These natural, synthetic, and hybrid materials offer a biomimetic structure, enhance cell attachment, and release bioactive molecules that promote the axonal extension of severed nerves. Scaffold-based preclinical studies have shown promising results on enhancing nerve repair; however, they are limited by the immune response and fabrication, scalability, and cost. Nevertheless, advances in manufacturing, including 3D bioprinting, and other strategies, such as gene editing by CRISPR, will overcome these shortcomings. The opportunity for the development of individualized approaches and specific treatment plans for each patient will also increase the effectiveness of bioactive materials for the treatment of nerve injuries. Combining bioactive materials with the neural interface can develop new reliable therapeutic solutions, particularly for neuroprosthetics. Finally, it is essential to stress a multidisciplinary focus, and future studies are needed to enhance the potential of bioactive materials for patients with nerve injuries and the field of regenerative medicine.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Graphene and Nanomaterials Applications · Neuroscience and Neural Engineering
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Department of Life Sciences, Yeungnam University, Gyeongsan 38541, Gyeongbuk, Republic of Korea
Department of Botany, Career Point University, Kota 324005, Rajasthan, India
Department of Botany, Government Lal Bahadur Shastri PG College, Sironj, Vidisha 464228, Madhya Pradesh, India
References (100+)
Show source-provided references
1. Peripheral Nerve Trauma: Mechanisms of Injury and Recovery10.1016/j.hcl.2013.04.002 ↗
2. Bordoni, M., Scarian, E., Rey, F., Gagliardi, S., Carelli, S., Pansarasa, O., and Cereda, C. (2020). Biomaterials in neurodegenerative disorders: A promising therapeutic approach. Int. J. Mol. Sci., 21.10.3390/ijms21093243 ↗
3. Nanocarrier-mediated brain delivery of bioactives for treatment/prevention of neurodegenerative diseases10.1016/j.jconrel.2020.02.015 ↗
4. Grinsell, D., and Keating, C.P. (2014). Peripheral Nerve Reconstruction after Injury: A Review of Clinical and Experimental Therapies. Biomed. Res. Int., 2014.10.1155/2014/698256 ↗
5. Anatomy and Physiology of the Blood–Brain Barriers10.1007/978-1-4614-9105-7_1 ↗
6. Drug delivery to the central nervous system10.1038/s41578-021-00394-w ↗
7. Approach to management of nerve gaps in peripheral nerve injuries10.1016/j.injury.2022.01.031 ↗
8. Current state of the surgical treatment of terminal neuromas10.1093/neuros/nyx500 ↗
9. End-to-Side Nerve Repair: Current Concepts and Future Perspectives10.1097/SAP.0000000000001663 ↗
10. Heinzel, J.C., Quyen Nguyen, M., Kefalianakis, L., Prahm, C., Daigeler, A., Hercher, D., and Kolbenschlag, J. (2021). A systematic review and meta-analysis of studies comparing muscle-in-vein conduits with autologous nerve grafts for nerve reconstruction. Sci. Rep., 11.10.1038/s41598-021-90956-3 ↗
11. Nerve grafting for peripheral nerve injuries with extended defect sizes10.1007/s10354-018-0675-6 ↗
12. Natural Bioactive Molecules as Neuromedicines for the Treatment/Prevention of Neurodegenerative Diseases10.1021/acsomega.2c06098 ↗
13. Rahman, M.H., Bajgai, J., Fadriquela, A., Sharma, S., Trinh, T.T., Akter, R., Jeong, Y.J., Goh, S.H., Kim, C.-S., and Lee, K.-J. (2021). Therapeutic Potential of Natural Products in Treating Neurodegenerative Disorders and Their Future Prospects and Challenges. Molecules, 26.10.3390/molecules26175327 ↗
14. Progress in biomaterials inspired by the extracellular matrix10.1016/j.giant.2024.100323 ↗
15. Biomaterials in treatment of Alzheimer’s disease10.1016/j.neuint.2021.105008 ↗
16. Alsuraifi, A., Mouzan, M.M., Ali, A.A.A., Algzaare, A., Aqeel, Z., Ezzat, D., and Ayad, A. (2025). Revolutionizing Tooth Regeneration: Innovations from Stem Cells to Tissue Engineering. Regen. Eng. Transl. Med., 1–26.10.1007/s40883-024-00382-w ↗
17. Shukla, A.K., Tiwari, A., Yadav, V.K., Yadav, V., Singh, M., Mishra, M.K., Pareek, A., and Jain, V. (2025). Innovative Approaches in Designing Neuro-compatible Biomaterials for Enhanced Neural Repair and Drug Delivery. Biomaterials and Neurodegenerative Disorders, Springer Nature.10.1007/978-981-97-9959-6_6 ↗
18. Revete, A., Aparicio, A., Cisterna, B.A., Revete, J., Luis, L., Ibarra, E., González, E.A.S., Molino, J., Reginensi, D., and Narain, R. (2022). Advancements in the Use of Hydrogels for Regenerative Medicine: Properties and Biomedical Applications. Int. J. Biomater., 2022.10.1155/2022/3606765 ↗
19. Biomimetic neural scaffolds: A crucial step towards optimal peripheral nerve regeneration10.1039/C8BM00260F ↗
20. Functional nanomaterials in peripheral nerve regeneration: Scaffold design, chemical principles and microenvironmental remodeling10.1016/j.mattod.2021.09.014 ↗
21. Khan, J., Rudrapal, M., Bhat, E.A., Ali, A., Alaidarous, M., Alshehri, B., Banwas, S., Ismail, R., and Egbuna, C. (2021). Perspective Insights to Bio-Nanomaterials for the Treatment of Neurological Disorders. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.724158 ↗
22. Emerging polymeric biomaterials and manufacturing-based tissue engineering approaches for neuro regeneration-A critical review on recent effective approaches10.1016/j.smaim.2022.11.007 ↗
23. SilkBridgeTM: A novel biomimetic and biocompatible silk-based nerve conduit10.1039/C9BM00783K ↗
24. The potential role of pomegranate and its nano-formulations on cerebral neurons in aluminum chloride induced Alzheimer rat model10.1016/j.sjbs.2020.04.045 ↗
25. Lopes, B., Sousa, P., Alvites, R., Branquinho, M., Sousa, A.C., Mendonça, C., Atayde, L.M., Luís, A.L., Varejão, A.S.P., and Maurício, A.C. (2022). Peripheral Nerve Injury Treatments and Advances: One Health Perspective. Int. J. Mol. Sci., 23.10.3390/ijms23020918 ↗
26. The biology of regeneration failure and success after spinal cord injury10.1152/physrev.00017.2017 ↗
27. Hussain, G., Wang, J., Rasul, A., Anwar, H., Qasim, M., Zafar, S., Aziz, N., Razzaq, A., Hussain, R., and de Aguilar, J.-L.G. (2020). Current Status of Therapeutic Approaches against Peripheral Nerve Injuries: A Detailed Story from Injury to Recovery. Int. J. Biol. Sci., 16.10.7150/ijbs.35653 ↗
28. Neurotrophic factors: Promising candidates in tissue regeneration10.4103/1673-5374.182696 ↗
29. Efficient Delivery of Nerve Growth Factors to the Central Nervous System for Neural Regeneration10.1002/adma.201900727 ↗
30. The brain-derived neurotrophic factor in neuronal plasticity and neuroregeneration: New pharmacological concepts for old and new drugs10.4103/1673-5374.233438 ↗
31. Myelin Lipids Inhibit Axon Regeneration Following Spinal Cord Injury: A Novel Perspective for Therapy10.1007/s12035-014-9072-3 ↗
32. Encapsulation of curcumin in self-assembling peptide hydrogels as injectable drug delivery vehicles10.1016/j.biomaterials.2011.04.069 ↗
33. Patel, J.C., Shukla, M., and Shukla, M. (2025). Cellular and Molecular Interactions in CNS Injury: The Role of Immune Cells and Inflammatory Responses in Damage and Repair. Cells, 14.10.3390/cells14120918 ↗
34. Bonferoni, M.C., Caramella, C., Catenacci, L., Conti, B., Dorati, R., Ferrari, F., Genta, I., Modena, T., Perteghella, S., and Rossi, S. (2021). Biomaterials for Soft Tissue Repair and Regeneration: A Focus on Italian Research in the Field. Pharmaceutics, 13.10.3390/pharmaceutics13091341 ↗
35. Askarzadeh, N., Nazarpak, M.H., Mansoori, K., Farokhi, M., Gholami, M., Mohammadi, J., and Mottaghitalab, F. (2020). Bilayer Cylindrical Conduit Consisting of Electrospun Polycaprolactone Nanofibers and DSC Cross-Linked Sodium Alginate Hydrogel to Bridge Peripheral Nerve Gaps. Macromol. Biosci., 20.10.1002/mabi.202000149 ↗
36. Hydrogels and Cell Based Therapies in Spinal Cord Injury Regeneration
37. Intrathecal delivery of a polymeric nanocomposite hydrogel after spinal cord injury10.1016/j.biomaterials.2010.07.004 ↗
38. Liposomes functionalized with acidic lipids rescue Aβ-induced toxicity in murine neuroblastoma cells10.1016/j.nano.2011.05.009 ↗
39. Neo-vascularization of the stroke cavity by implantation of human neural stem cells on VEGF-releasing PLGA microparticles10.1016/j.biomaterials.2012.06.085 ↗
40. Harley-Troxell, M.E., Steiner, R., Advincula, R.C., Anderson, D.E., and Dhar, M. (2023). Interactions of Cells and Biomaterials for Nerve Tissue Engineering: Polymers and Fabrication. Polymers, 15.10.3390/polym15183685 ↗
41. Differentiation of neuronal stem cells into motor neurons using electrospun poly-l-lactic acid/gelatin scaffold10.1016/j.biomaterials.2013.09.097 ↗
42. Stimuli-responsive nanomaterials for biomedical applications10.1021/ja510147n ↗
43. Tuning β-sheet peptide self-assembly and hydrogelation behavior by modification of sequence hydrophobicity and aromaticity10.1021/bm200510k ↗
44. A hyperbranched dopamine-containing PEG-based polymer for the inhibition of α-synuclein fibrillation10.1016/j.bbrc.2015.12.060 ↗
45. Promising Targets for the Treatment of Neurodegenerative Diseases10.1002/cpt.195 ↗
46. The therapeutic contribution of nanomedicine to treat neurodegenerative diseases via neural stem cell differentiation10.1016/j.biomaterials.2017.01.032 ↗
47. Nanoparticles mediating the sustained puerarin release facilitate improved brain delivery to treat parkinson’s disease10.1021/acsami.9b16047 ↗
48. Hydrogel-delivered brain-derived neurotrophic factor promotes tissue repair and recovery after stroke10.1177/0271678X16649964 ↗
49. Designer Self-Assemble Peptides Maximize the Therapeutic Benefits of Neural Stem Cell Transplantation for Alzheimer’s Disease via Enhancing Neuron Differentiation and Paracrine Action10.1007/s12035-014-9069-y ↗
50. Devnarain, N., Osman, N., Fasiku, V.O., Makhathini, S., Salih, M., Ibrahim, U.H., and Govender, T. (2021). Intrinsic stimuli-responsive nanocarriers for smart drug delivery of antibacterial agents—An in-depth review of the last two decades. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol., 13.10.1002/wnan.1664 ↗
51. Guo, B., Lei, B., Li, P., and Ma, P.X. (2015). Functionalized scaffolds to enhance tissue regeneration. Regen. Biomater., 2.10.1093/rb/rbu016 ↗
52. Huang, W.H., Ding, S.L., Zhao, X.Y., Li, K., Guo, H.T., Zhang, M.Z., and Gu, Q. (2023). Collagen for neural tissue engineering: Materials, strategies, and challenges. Mater. Today Bio, 20.10.1016/j.mtbio.2023.100639 ↗
53. Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration10.4103/1673-5374.336132 ↗
54. Natural biomaterials in brain repair: A focus on collagen10.1016/j.neuint.2021.105033 ↗
55. Li, X., Zhang, X., Hao, M., Wang, D., Jiang, Z., Sun, L., Gao, Y., Jin, Y., Lei, P., and Zhuo, Y. (2022). The application of collagen in the repair of peripheral nerve defect. Front. Bioeng. Biotechnol., 10.10.3389/fbioe.2022.973301 ↗
56. Subramanian, A., Krishnan, U.M., and Sethuraman, S. (2009). Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J. Biomed. Sci., 16.10.1186/1423-0127-16-108 ↗
57. Biomaterial applications in neural therapy and repair
58. Wosicka-Frąckowiak, H., Poniedziałek, K., Woźny, S., Kuprianowicz, M., Nyga, M., Jadach, B., and Milanowski, B. (2024). Collagen and Its Derivatives Serving Biomedical Purposes: A Review. Polymers, 16.10.20944/preprints202408.1673.v1 ↗
59. Lipid-based nanoparticles with high binding affinity for amyloid-β1–42 peptide10.1016/j.biomaterials.2010.04.044 ↗
60. Combination of a peptide-modified gellan gum hydrogel with cell therapy in a lumbar spinal cord injury animal model10.1016/j.biomaterials.2016.07.019 ↗
61. Chitosan—An alternative drug delivery approach for neurodegenerative diseases
62. Kołodziejska, M., Jankowska, K., Klak, M., and Wszoła, M. (2021). Chitosan as an Underrated Polymer in Modern Tissue Engineering. Nanomaterials, 11.10.3390/nano11113019 ↗
63. High molecular weight water-soluble chitosan protects against apoptosis induced by serum starvation in human astrocytes10.1016/S0955-2863(01)00218-2 ↗
64. Chitosan chemistry and pharmaceutical perspectives10.1021/cr030441b ↗
65. Enzymatic degradation of β-chitin: Susceptibility and the influence of deacetylation10.1016/S0144-8617(99)00127-7 ↗
66. Chitosan-Chitosan derivative for cartilage associated disorders: Protein interaction and biodegradability
67. Preparation and Testing of Quaternized Chitosan Nanoparticles as Gene Delivery Vehicles10.1007/s12010-015-1483-8 ↗
68. Li, J., Cai, C., Li, J., Li, J., Li, J., Sun, T., Wang, L., Wu, H., and Yu, G. (2018). Chitosan-Based Nanomaterials for Drug Delivery. Molecules, 23.10.3390/molecules23102661 ↗
69. Silk Fibroin Hydrogels Could Be Therapeutic Biomaterials for Neurological Diseases10.1155/2022/2076680 ↗
70. Yonesi, M., Garcia-Nieto, M., Guinea, G.V., Panetsos, F., Pérez-Rigueiro, J., and González-Nieto, D. (2021). Silk Fibroin: An Ancient Material for Repairing the Injured Nervous System. Pharmaceutics, 13.10.3390/pharmaceutics13030429 ↗
71. Silk fibroin-based biomaterials for disc tissue engineering10.1039/D2BM01343F ↗
72. Platelet lysate and adipose mesenchymal stromal cells on silk fibroin nonwoven mats for wound healing10.1002/app.42942 ↗
73. A dual-layer silk fibroin scaffold for reconstructing the human corneal limbus10.1016/j.biomaterials.2012.01.045 ↗
74. Biomedical Applications of Recombinant Silk-Based Materials10.1002/adma.201704636 ↗
75. Brain drug delivery and neurodegenerative diseases: Polymeric PLGA-based nanoparticles as a forefront platform10.1016/j.arr.2022.101658 ↗
76. Lu, Y., Cheng, D., Niu, B., Wang, X., Wu, X., and Wang, A. (2023). Properties of Poly (Lactic-co-Glycolic Acid) and Progress of Poly (Lactic-co-Glycolic Acid)-Based Biodegradable Materials in Biomedical Research. Pharmaceuticals, 16.10.3390/ph16030454 ↗
77. Biodegradable, pH-Responsive Carboxymethyl Cellulose/Poly(Acrylic Acid) Hydrogels for Oral Insulin Delivery10.1002/mabi.201300384 ↗
78. Biodegradability study of polylactic acid/thermoplastic polyurethane blends10.1016/j.polymertesting.2015.07.011 ↗
79. Polymer degradation and drug delivery in PLGA-based drug–polymer applications: A review of experiments and theories10.1002/jbm.b.33648 ↗
80. Microfluidic assisted synthesis of PLGA drug delivery systems10.1039/C8RA08972H ↗
81. Poly Lactic-co-Glycolic Acid (PLGA) as Biodegradable Controlled Drug Delivery Carrier10.3390/polym3031377 ↗
82. Manto, K.M., Govindappa, P.K., Martinazzi, B., Han, A., Hegarty, J.P., Koroneos, Z., Talukder, M.A.H., and Elfar, J.C. (2022). Erythropoietin-PLGA-PEG as a local treatment to promote functional recovery and neurovascular regeneration after peripheral nerve injury. J. Nanobiotechnol., 20.10.1186/s12951-022-01666-5 ↗
83. Homaeigohar, S., and Boccaccini, A.R. (2022). Nature-Derived and Synthetic Additives to poly(ɛ-Caprolactone) Nanofibrous Systems for Biomedicine; an Updated Overview. Front. Chem., 9.10.3389/fchem.2021.809676 ↗
84. Electrospun poly(ɛ-caprolactone)/gelatin nanofibrous scaffolds for nerve tissue engineering10.1016/j.biomaterials.2008.08.007 ↗
85. Smart electrospun nanofibers containing PCL/gelatin/graphene oxide for application in nerve tissue engineering10.1016/j.msec.2019.109768 ↗
86. Electrospun poly(lactic acid) membranes with defined pore size to enhance cell infiltration10.1016/j.heliyon.2024.e36091 ↗
87. Nanoparticle-based targeted drug delivery10.1016/j.yexmp.2008.12.004 ↗
88. Bianchini, M., Micera, S., and Redolfi Riva, E. (2023). Recent Advances in Polymeric Drug Delivery Systems for Peripheral Nerve Regeneration. Pharmaceutics, 15.10.3390/pharmaceutics15020640 ↗
89. Qin, X., Wu, Y., Liu, S., Yang, L., Yuan, H., Cai, S., Flesch, J., Li, Z., Tang, Y., and Li, X. (2022). Surface Modification of Polycaprolactone Scaffold With Improved Biocompatibility and Controlled Growth Factor Release for Enhanced Stem Cell Differentiation. Front. Bioeng. Biotechnol., 9.10.3389/fbioe.2021.802311 ↗
90. Rosuvastatin-Eluting Gold-Nanoparticle-Loaded Perivascular Wrap for Enhanced Arteriovenous Fistula Maturation in a Murine Model10.1007/s42765-023-00315-2 ↗
91. Controlled Delivery of Rosuvastatin or Rapamycin through Electrospun Bismuth Nanoparticle-Infused Perivascular Wraps Promotes Arteriovenous Fistula Maturation10.1021/acsami.4c06042 ↗
92. Castañeda-Rodríguez, S., González-Torres, M., Ribas-Aparicio, R.M., Del Prado-Audelo, M.L., Leyva-Gómez, G., Gürer, E.S., and Sharifi-Rad, J. (2023). Recent advances in modified poly (lactic acid) as tissue engineering materials. J. Biol. Eng., 17.10.1186/s13036-023-00338-8 ↗
93. Medical applications and prospects of polylactic acid materials10.1016/j.isci.2024.111512 ↗
94. Polylactic acid: Synthesis and biomedical applications10.1111/jam.14290 ↗
95. 3D printing of polylactic acid: Recent advances and opportunities10.1007/s00170-022-10795-y ↗
96. Zhang, M., Li, C., Zhou, L.P., Pi, W., and Zhang, P.X. (2021). Polymer Scaffolds for Biomedical Applications in Peripheral Nerve Reconstruction. Molecules, 26.10.3390/molecules26092712 ↗
97. A review on poly lactic acid (PLA) as a biodegradable polymer10.1007/s00289-022-04160-y ↗
98. Biocompatibility, biodegradation and excretion of polylactic acid (PLA) in medical implants and theranostic systems10.1016/j.cej.2018.01.010 ↗
99. Current applications of poly(lactic acid) composites in tissue engineering and drug delivery10.1016/j.compositesb.2020.108238 ↗
100. Liang, H.Y., Lee, W.K., Hsu, J.T., Shih, J.Y., Ma, T.L., Vo, T.T.T., Lee, C.W., Cheng, M.T., and Lee, I.T. (2024). Polycaprolactone in Bone Tissue Engineering: A Comprehensive Review of Innovations in Scaffold Fabrication and Surface Modifications. J. Funct. Biomater., 15.10.3390/jfb15090243 ↗